Vaccinex, Inc. announced that it has entered into a stock purchase agreement pursuant to which the company agreed to issue and sell to the investors named therein an aggregate of 3,733,973 shares of common stock at par value of $0.0001 per share at a purchase price of $0.156 per share for aggregate gross proceeds of approximately 582,500 on September 20, 2023. The sale of the shares was not registered under the Securities Act of 1933, as amended and the shares were issued and sold in a private placement pursuant to Section 4(a)(2) of the 1933 Act and Rule 506 of Regulation D as promulgated by the Securities and Exchange Commission under the 1933 Act.